BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29574096)

  • 1. Measurement of indicator genes using global complementary DNA (cDNA) amplification, by polyadenylic acid reverse transcriptase polymerase chain reaction (poly A RT-PCR): A feasibility study using paired samples from tissue and ductal juice in patients undergoing pancreatoduodenectomy.
    Sanyal S; Siriwardena AK; Byers R
    Pancreatology; 2018 Jun; 18(4):458-462. PubMed ID: 29574096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(adenylic acid) complementary DNA real-time polymerase chain reaction in pancreatic ductal juice in patients undergoing pancreaticoduodenectomy.
    Oliveira-Cunha M; Byers RJ; Siriwardena AK
    Pancreas; 2010 Mar; 39(2):171-4. PubMed ID: 19940796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of mesothelin mRNA in pure pancreatic juice from patients with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas, and chronic pancreatitis.
    Watanabe H; Okada G; Ohtsubo K; Yamaguchi Y; Mouri H; Motoo Y; Wakabayashi T; Sawabu N
    Pancreas; 2005 May; 30(4):349-54. PubMed ID: 15841046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(A) RT-PCR measurement of diagnostic genes in pancreatic juice in pancreatic cancer.
    Oliveira-Cunha M; Byers RJ; Siriwardena AK
    Br J Cancer; 2011 Feb; 104(3):514-9. PubMed ID: 21245863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.
    Aso T; Ohtsuka T; Tamura K; Ideno N; Kono H; Nagayoshi Y; Ohuchida K; Ueda J; Takahata S; Shindo K; Aishima S; Oda Y; Mizumoto K; Tanaka M
    Pancreas; 2014 Apr; 43(3):361-6. PubMed ID: 24622064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
    Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Int J Cancer; 2007 Apr; 120(8):1634-40. PubMed ID: 17236203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice.
    Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Maekawa S; Mochizuki K; Kawaida H; Itakura J; Katoh R; Fujii H; Sato T; Enomoto N
    Pancreas; 2017; 46(10):1281-1287. PubMed ID: 28930868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
    Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
    Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing.
    Kuratomi N; Takano S; Fukasawa M; Maekawa S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Takada H; Nakakuki N; Kato R; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Inoue T; Kondo T; Ichikawa D; Enomoto N
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
    Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
    Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer.
    Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Maekawa S; Mochizuki K; Kawaida H; Kono H; Itakura J; Sato T; Ichikawa D; Enomoto N
    Pancreas; 2019 Sep; 48(8):1032-1040. PubMed ID: 31404021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
    Tanaka M
    Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
    Shirai Y; Sogawa K; Yamaguchi T; Sudo K; Nakagawa A; Sakai Y; Ishihara T; Sunaga M; Nezu M; Tomonaga T; Miyazaki M; Saisho H; Nomura F
    Hepatogastroenterology; 2008; 55(86-87):1824-9. PubMed ID: 19102401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography.
    Shimamoto T; Tani M; Kawai M; Hirono S; Ina S; Miyazawa M; Shimizu A; Uchiyama K; Yokoyama S; Tsutsumi M; Yamaue H
    Pancreas; 2010 Aug; 39(6):879-83. PubMed ID: 20357691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic intraductal papillary mucinous neoplasm: Case report and review of the literature].
    Pasqua A; Oddi R; Lancelotti T; Salgado R; Salgado R; Soifer L
    Acta Gastroenterol Latinoam; 2015 Mar; 45(1):85-9. PubMed ID: 26076521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.
    Fukushima N; Walter KM; Uek T; Sato N; Matsubayashi H; Cameron JL; Hruban RH; Canto M; Yeo CJ; Goggins M
    Cancer Biol Ther; 2003; 2(1):78-83. PubMed ID: 12673124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas.
    Tsutsumi K; Sato N; Cui L; Mizumoto K; Sadakari Y; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Tanaka M
    Mod Pathol; 2011 Apr; 24(4):533-41. PubMed ID: 21102412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
    Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H
    Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms.
    Yu J; Sadakari Y; Shindo K; Suenaga M; Brant A; Almario JAN; Borges M; Barkley T; Fesharakizadeh S; Ford M; Hruban RH; Shin EJ; Lennon AM; Canto MI; Goggins M
    Gut; 2017 Sep; 66(9):1677-1687. PubMed ID: 27432539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.